SCHEMBL6288115

SCHEMBL6288115

CCOC(=O)c1sc(Cl)nc1-c1cccc(C#N)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.54
FNTB P49356 1/20 0.54
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 1/20 0.50
DHODH Q02127 7/20 0.49
TRPM8 Q7Z2W7 1/20 0.48
HPGD P15428 1/20 0.48
CDC7 O00311 4/20 0.47
DBF4 Q9UBU7 4/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
TLR8 Q9NR97 1/20 0.46
TLR7 Q9NYK1 1/20 0.46
SETD7 Q8WTS6 1/20 0.45
CNR2 P34972 1/20 0.44
GRM5 P41594 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1919770 0.88 FNTA (0.55) FNTAFNTBALDH1A1HSD17B10DHODH
SCHEMBL6288104 0.87 ALDH1A1 (0.69) FNTAFNTBALDH1A1HSD17B10DHODH
SCHEMBL2492109 0.85 TRPM8 (0.65) ALDH1A1HSD17B10DHODHTRPM8HPGD
SCHEMBL11281010 0.85 ALDH1A1 (0.55) ALDH1A1HSD17B10DHODHTRPM8HPGD
SCHEMBL6279541 0.85 DHODH (0.55) FNTAFNTBALDH1A1HSD17B10DHODH
SCHEMBL6285875 0.82 FNTA (0.47) FNTAFNTBALDH1A1
SCHEMBL3893108 0.82 ALDH1A1 (0.71) ALDH1A1HSD17B10DHODHTRPM8HPGD
SCHEMBL6288098 0.81 CDC7 (0.68) FNTAFNTBALDH1A1HSD17B10TRPM8
SCHEMBL6286606 0.81 DHODH (0.75) DHODHHPGDMEN1CYP1A2CYP2C9
SCHEMBL2493738 0.80 MAPT (0.65) ALDH1A1HSD17B10DHODHTRPM8HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962935-B2 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-20040073029-A1 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors PRUITT JAMES RUSSELL (US) 2004-04-15 US disclosed
US-6569874-B1 Such as 2-acetylamino-4-(3-amidinophenyl)-5-((2'-amino-sulfonyl-(1,1')-biphen-4 -yl)aminocarbonyl)thiazole; for treatment of thromboembolic disorders BRISTOL-MYERS SQUIBB COMPANY 2003-05-27 US disclosed
EP-0946528-B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-04-09 EP disclosed
US-6187797-B1 ANTICOAGULANTS; TRYPSINE-LIKE SERINE PROTEASE INHIBITORS DUPONT PHARMACEUTICALS COMPANY 2001-02-13 US disclosed
EP-0946528-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073029-A1 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors F12, XDH, F2 FNTA 3536/4885FNTB 1556/4885ALDH1A1 596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.